Duck virus hepatitis: serial passage of attenuated virus in ducklings.
The safety of three attenuated virus vaccines of proven efficacy against duck virus hepatitis was assessed by controlled laboratory studies which involved the serial transmission of the virus through groups of two-day-old ducklings known to be susceptible to the disease. Each vaccine was initially derived from a different source. Enhancement of virulence which resulted in deaths from the disease in test groups of ducklings occurred in each instance.
D000818:Animals; D004372:Ducks / Q000382:microbiology*; D004770:Enterovirus / Q000254:growth & development*; D004769:Enterovirus Infections / Q000517:prevention & control / Q000662:veterinary; D004371:Hepatitis Virus, Duck / Q000254:growth & development* / Q000276:immunology / Q000302:isolation & purification; D008099:Liver / Q000382:microbiology; D011201:Poultry Diseases / Q000517:prevention & control; D014613:Vaccines, Attenuated / Q000276:immunology; D014765:Viral Vaccines; D014774:Virulence
D014613:Vaccines, Attenuated; D014765:Viral Vaccines